Susan Dexter

Chief Technical Officer, Sonnet BioTherapeutics Holdings, Inc.

Companies

Sonnet BioTherapeutics Holdings, Inc.Board member Dec 3, 2025 to now¹
Sonnet BioTherapeutics Holdings, Inc.Chief Technical Officer Apr 3, 2020 to now²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 2, 2025Returned to company 9,643 shares of Sonnet BioTherapeutics Holdings, Inc.³
Jul 11, 2025Granted 8,000 shares of Sonnet BioTherapeutics Holdings, Inc.⁴
Dec 11, 2023Granted 1,452 shares of Sonnet BioTherapeutics Holdings, Inc.⁵
Jun 14, 2023Bought 10,000 shares at $0.70 of Sonnet BioTherapeutics Holdings, Inc.⁶
Jan 7, 2023Granted 14,627 shares of Sonnet BioTherapeutics Holdings, Inc.⁷
Jan 7, 2023Returned to company 14,627 shares of Sonnet BioTherapeutics Holdings, Inc.⁷
Dec 14, 2022Granted 14,627 shares of Sonnet BioTherapeutics Holdings, Inc.⁸
Dec 15, 2021Granted 63,104 shares of Sonnet BioTherapeutics Holdings, Inc.⁹

The numbers on this page point here. Each one links to the record it came from.